A 1-day fear memory in ethanol withdrawn (ETOH) rats is resistant to destabilization-reconsolidation process. However, D-cycloserine (DCS) reverts this disturbance. Considering that the formation of pathological fear memories in humans often occurs long time before the requirement of an intervention, the study of older memories is relevant in ETOH rats. In addition, the resistance to destabilization and DCS effect on this memory phase at molecular level in ETOH rats have not been corroborated yet. Firstly, we examined the effect of a pharmacological intervention after reactivation on reconsolidation of a 7-day fear memory in ETOH rats. Then, and considering that enhanced GluN2B expression and ubiquitin-proteasome system (UPS) activity are involved in destabilization, we evaluated them following reactivation in ETOH rats. Furthermore, DCS effect on such destabilization markers was examined. It was found that the pharmacological intervention after reactivation did not affect the 7-day fear memory in ETOH rats with DCS reversing this resistance. Memory reactivation increased GluN2B expression, polyubiquitination levels and proteasome activity in the basolateral amygdala complex (BLA) of control (CON) rats only; without affecting these molecular events in ETOH rats. Finally, ETOH rats treated with DCS and CON animals displayed elevated and similar UPS activities in the BLA after reactivation. In conclusion, the reactivation of an older fear memory formed during ethanol withdrawal does not trigger the molecular events associated with destabilization, and DCS facilitates this memory phase by enhancing the UPS activity.
Introduction
Under certain conditions, the reactivation of consolidated memories can induce a transient labile phase followed by a re-stabilization period, referred to as reconsolidation (Alberini, 2005; Nader et al., 2000; Tronson and Taylor, 2007) . Memory destabilization involves protein degradation whereas memory reconsolidation requires new protein synthesis. The administration of pharmacological and non-pharmacological interventions during this unstable phase can impair the reconsolidation process, thereby affecting the original memory trace. Thus, memory reconsolidation disruption has been tentatively suggested to be a therapeutical strategy for weakening memories associated with psychiatric disorders (Tronson and Taylor, 2013) .
It has been observed that fear memory recall promotes an increase in the alcohol intake in ethanol dependent rats (Bertotto et al., 2010) , indicating a possible role of aversive memories in the maintenance of alcoholism. Fear memory in ethanol withdrawn (ETOH) animals is persistent, robust and resistant to extinction (Bertotto et al., 2006) .
Moreover, 1-day fear memory is less susceptible to Propranolol (PROP) disruption after reactivation in ETOH rats, indicating a resistance to the destabilization-reconsolidation process (Ortiz et al., 2015; Ortiz et al., 2016) . Behavioral findings demonstrated that pre-retrieval D-cycloserine (DCS; a partial agonist of the glycine recognition site of the NMDA receptor) administration promotes the destabilization of resistant memories, including fear memory in ETOH rats (Bustos et al., 2010; Gazarini et al., 2014; Ortiz et al., 2015; Ortiz et al., 2016) .
From a clinical perspective, it is more relevant to determine the effectiveness of a treatment for the attenuation of older than recent aversive memories, because the formation of pathological fear memories often occurs long time before the appearance of the symptoms requiring an intervention. Accordingly, the study of an older fear memory in ETOH rats would provide evidence with major impact in the clinical context. It has been reported that memory processing is altered with the passage of time in both physiological and pathological conditions (An et al., 2017; Bustos et al., 2010; Finnie and Nader, 2012; Inda et al., 2011; Wang et al., 2009 ). Related to this, the resistance to reconsolidation interference of a fear memory in stressed rats becomes more evident in older (7 and 21-day) than recent (1-day) memories (Bustos et al., 2010) . However, DCS restores the vulnerability to disruption following reactivation of a 7-day fear memory in stressed rats (Bustos et al., 2010) . Thus, a resistance to reconsolidation disruption could be expected in a 7-day fear memory in ETOH rats which could be rescued by DCS.
Pharmacological and molecular findings have suggested that the destabilization phase of an aversive memory involves an increase in protein degradation by the ubiquitin-proteasome system (UPS), evidenced as enhanced polyubiquitinated protein levels and proteasome activity in the amygdala (Jarome et al., 2016; Jarome et al., 2011) . It has been suggested that this mechanism is dependent on the activation of NMDA receptors containing the GluN2B subunit [NMDA-R (GluN2B)] (Ben Mamou et al., 2006; Jarome and Helmstetter, 2013; Li et al., 2013; Milton et al., 2013) . Related to this, an enhanced GluN2B subunit expression in the basolateral amygdala complex (BLA) was associated with the labilization memory phase (Espejo et al., 2016) . To date, the resistance to memory destabilization in ETOH rats at molecular level has not been investigated.
Intra-BLA Propranolol (PROP) infusion is not efficient at disrupting memory reconsolidation in ETOH rats, but pre-reactivation DCS administration facilitates the PROP effect, suggesting that NMDA receptors, potentially in the BLA, are involved in the resistance to memory destabilization-reconsolidation observed in these animals (Ortiz et al., 2015) . Accordingly, it may be predicted that fear memory reactivation does not trigger the destabilization molecular events in the BLA of ETOH rats.
The role of DCS as a facilitator of destabilization phase in resistant memories (Bustos et al., 2010; Espejo et al., 2016; Gazarini et al., 2014; Ortiz et al., 2015; Ortiz et al., 2016) was only evidenced by pharmacological studies. Hence, we considered it important to examine the effect of pre-reactivation DCS administration on destabilization molecular markers. DCS increases the activation probability of NMDAR and it has been indicated that DCS favors memory extinction through proteasome activity (Mao et al., 2008) . Hence, it could be expected that DCS facilitates destabilization through an increase in the UPS activity.
Considering the above, our first goal was to evaluate the vulnerability to post-reactivation interference of a 7-day fear memory in ETOH animals. Next, we examined the GluN2B subunit expression, polyubiquitination levels and proteasome activity in the BLA of ETOH animals after reactivation. Finally, we evaluated the polyubiquitination levels and proteasome activity in the BLA of ETOH animals treated with DCS before reminder.
Materials and methods

Animals and chronic ethanol administration
Adult male Wistar rats were maintained in a 12-h light-dark cycle (lights on at 0700) at a room temperature of 21-22°C, with food and water available ad libitum except when detailed otherwise in the protocol. Animals were housed in groups of 2-4 per cage and habituated to housing conditions and experimenter handling for 1 week before the start of the experiments. Separate groups of rats were used for each experiment, with animals being randomly assigned to the treatments, drug injections and behavioral tests. All testing took place between 10:00 and 13:00 h, and the experiments were performed by a person who was blind to the experimental conditions of the animals. The protocols used were approved by the Animal Care Committee of the Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, and are consistent with the NIH Guide for the Care and Use of Laboratory Animals. Rats were made dependent on ethanol by administration of 6% (v/v) of ethanol in a nutritionally complete liquid diet (Ensure, chocolate flavor, Abbott Laboratories B.V.), as previously described (Ortiz et al., 2015) . Control (CON) animals were pair-fed with the same diet, but with dextrose substituted isocalorically for ethanol. After 14 days, the liquid diet administration was interrupted and animals were subsequently fed with laboratory chow.
Drug administration
DL-Propranolol hydrochloride (PROP) and D-cycloserine (DCS) (Sigma-Aldrich, St. Louis, MO, USA) were both dissolved in saline (SAL, 0.9% w/v) at concentrations of 10 mg/ml and 5 mg/ml, respectively, for i.p. injection (Ortiz et al., 2015; Ortiz et al., 2016) . The total volume of drug used or an equivalent amount of SAL was 1.0 ml/kg.
Contextual fear conditioning
Contextual fear conditioning (FC) took place in standard training chambers as previously described (Ortiz et al., 2015) . Three days after interruption of the diet treatment, rats were individually placed in the chamber and after 3 min received 3 unsignaled scrambled footshocks (0.5 mA of 3 s duration with a 30 s intershock interval). Animals were kept in the chamber for an additional 50 s, before being immediately brought back to the colony room. Memory reactivation session (retrieval) took place 1 week after learning, and consisted of re-exposing rats to the training context for 5 min without shock delivery. The memory retention test (Test) was performed 1 day after reactivation and consisted of re-exposing rats to the training context for 5 min without shock delivery. The freezing response of each rat was scored during the reactivation and testing sessions. The total time spent freezing in each period was quantified (in seconds) manually using a stopwatch. Freezing, a commonly used index of fear in rats (Blanchard and Blanchard, 1969) , was defined as the total absence of body and head movement except that associated with breathing. Freezing was scored by a person who was unaware of the experimental conditions of each animal. As the fear training protocol employed induced a similar freezing response in both the CON and ETOH groups, we discarded the possibility that the potential differences obtained in the experiments were dependent on the expression of freezing (Ortiz et al., 2015; Ortiz et al., 2016) .
Tissue processing
Rats were euthanized by decapitation and brains were quickly removed. The bilateral BLA was dissected from coronal brain slices of 2 mm using an acrylic brain matrix (Stoelting CO.) on ice. According to the BLA boundaries defined by Paxinos and Watson (2009) , BLA enriched tissue being collected using a 2 mm micro punch under a magnifying glass. Lysis buffer (25 mM HEPES; 0.5 M NaCl; 2 mM EDTA; 1 mM DTT; 0.1% NP40) with protease and phosphatase inhibitors (1 mM orthovanadate; 1 mM PMSF; 10 μg/ml leupeptin; 10 μg/ml aprotinin; 1 μg/ml pepstatin) were added to the BLA samples, and the tissue was disrupted by brief sonication and centrifuged at 20000g for 2 min at 4°C (Espejo et al., 2016) . The supernatants were stored at −70°C until use and protein yield was quantified using the Bradford assay (Biorad).
Western blot
The samples were combined with sample buffer (50% Glycerol; 4% SDS; 125 mM Tris pH 6.8; 400 mM DTT; 0.02% bromophenol blue) and boiled at 100°C for 5 min. Protein samples (40 μg for polyubiquitinated protein or 15 μg for GluN2B subunit) were separated on 7.5% SDS -polyacrylamide gel electrophoresis (PAGE), transferred to nitrocellulose membranes as previously described (Bertotto et al., 2011) , and blocked for 1 h. To evaluate polyubiquitinated protein expression, we used an antibody that recognizes lysine-K48 linked ubiquitin chains (anti-Ubiquitin-lys-k48, Millipore), which are degradation-specific polyubiquitin tags (Jarome et al., 2011) . Blots were incubated with anti-Ubiquitin-lys-k48 (1:750, Millipore), followed by incubation with horseradish peroxidase-conjugated secondary antibody. Actin (Sigma) was used as a loading control and the obtained film samples were scanned. To examine the GluN2B subunit, blots were incubated with an antibody anti-GluN2B subunit (1:750; Cell Signaling Technology), followed by incubation with IRDye® 800 WC Donkey Anti-Rabbit IgG. Tubulin (Sigma) was used as a loading control. The bands were visualized by scanning using an LI-COR Odyssey imager. All images were analyzed by the Gelpro31 program.
Proteasome assays
The chymotrypsin-like activity of the proteasome was measured using the 20S Proteasome Activity Assay Kit (APT280, Millipore; (Werner et al., 2015) ). The reaction was incubated at 37°C for 120 min, and then the fluorescence was registered at 360 (excitation)/ 460 (emission) on a monochromatic plate reader (Biotek). Protein free blanks were used and an AMC standard curve was produced. The unit of chymotrypsin-like activity of the proteasome was defined as the pmol of AMC generated per μg of proteins at 37°C for 120 min.
Experimental design 2.7.1. Experiment 1
The goal of this experiment was to evaluate the vulnerability to reconsolidation interference of a 7-day fear memory in ETOH rats. Animals from the CON and ETOH groups were fear conditioned as described in Materials and Methods. Seven days after training, rats received DCS (5 mg/kg; i.p.) or SAL 30 min before a 5 min reactivation session. Immediately after, rats were injected with PROP (10 mg/Kg, i.p) or SAL, with memory retention being evaluated the following day (Test). The experimental design is displayed in Fig. 1a. 
Experiment 2
The goal of this experiment was to examine the memory reactivation effect on the GluN2B subunit expression, polyubiquitination levels and proteasome activity in the BLA of ETOH rats. Animals from the CON and ETOH groups were fear conditioned, and 1 week later were sacrificed without a reactivation session (non-reactivated groups, NR) or 60 min after reminder (reactivated groups, R) (Espejo et al., 2016; Jarome et al., 2011) . The expression of the GluN2B subunit and polyubiquitinated protein were analyzed by Western blot, and the catalytic activity of proteasome was measured using a commercial kit. The results were expressed as a percentage of the NR-CON group. The corresponding timelines can be observed in Figs. 2a, 3a and 4a.
Experiment 3
Here, we evaluated the effect of pre-reminder DCS administration on protein polyubiquitination and chymotrypsin-like proteasome activity in the BLA of ETOH rats. To carry this out, 7 days after fear training ETOH rats were injected with DCS or SAL 30 min prior to memory reactivation and sacrificed one hour later. The results were expressed as a percentage of reactivated CON (R-CON) rats injected with SAL before reactivation. These CON rats received the liquid diet, training and reminder at the same time that ETOH groups. The experimental design is shown in Fig. 5a .
Several behavioral findings have indicated that the facilitating effect of DCS on the destabilization process in resistant memories is dependent on the reactivation session, and that this drug does not affect this memory phase in CON rats (Espejo et al., 2016; Gazarini et al., 2014; Ortiz et al., 2015; Ortiz et al., 2016) . Moreover, Espejo et al. (2016) reported that CON animals treated with SAL or DCS before memory reactivation showed similar expressions of Zif-268, indicating that DCS in CON rats does not modify the expression of this transcription factor in the reconsolidation process. Therefore, to minimize the number of animals used, neither the NR groups nor the R-CON rats treated with DCS were included in the experimental designs.
Statistical analyses
Results were expressed as the mean ± S.E.M, and the data were analyzed by the student's t-test or ANOVAs followed by the Tukey's HSD post-hoc test (p < .05 was regarded as significant). Each animal was only used once.
Results
Experiment 1: A 7-day fear memory is not susceptible to reconsolidation disruption in ethanol withdrawn rats. Effect of D-cycloserine.
As can be observed in Fig. 1c , CON animals injected with PROP showed decreased freezing levels, regardless of the pre-reactivation treatment. Moreover, PROP was ineffective at reducing the fear response in ETOH rats that received a pre-reactivation SAL injection. However, ETOH animals treated with DCS-PROP showed a decreased freezing response that did not differ from those shown by the CON-PROP groups. ANOVA revealed significant diet treatment x pre-reactivation drug x post-reactivation drug interactions for memory retention test [F(1,32) = 6.67; p < .05]. Tukey's test revealed that freezing levels of DCS-PROP and SAL-PROP from the CON group and DCS-PROP from the ETOH group did not differ from each other and were significantly lower than the remaining groups. Nevertheless, regardless of the pre-reactivation treatment, all rats showed similar fear (Fig. 1b) .
Experiment 2: Fear memory reactivation does not increase GluN2B subunit expression or UPS activity in the BLA of ETOH rats.
Memory reactivation increased the GluN2B subunit expression, polyubiquitinated protein expression and chymotrypsin-like proteasome activity in the BLA but only in CON rats (Figs. 2c, 3c and 4c, respectively). The protein levels and enzymatic activity were similar and comparable between R-ETOH rats and non-reactivated groups. A two-way ANOVA indicated a significant diet treatment x reactivation interaction for GluN2B [F(1,33) = 7.39; p < .05], polyubiquitinated protein expression [F (1,25) = 17.57, p < .05] and proteasome activity [F (1,24) = 17.31, p < .05]. Furthermore, Tukey's test revealed that the reactivated CON animals exhibited a significantly greater expression of the GluN2B subunit (Fig. 2c) , polyubiquitination ( Fig. 3c ) and enzymatic proteasome activity (Fig. 4c) in the BLA than the remaining groups. As expected, CON and ETOH animals displayed equivalent levels of freezing during fear recall ([t = 0.10; df = 17; p > .05], Experiment 3: Pre-reactivation D-cycloserine administration restores the enhancement of protein polyubiquitination and proteasome activity in the BLA of ETOH rats. Fig. 5c and f show that animals from the ETOH-SAL group exhibited decreased UPS activity, while R-CON and ETOH-DCS groups displayed elevated and similar UPS activity. One-way ANOVA indicated a Fig. 2 . Fear memory reactivation does not promote an increase of GluN2B subunit expression in the BLA of ETOH rats. aExperimental design. b-Freezing response during reactivation. c-GluN2B levels in the BLA. d-Representative blots for GluN2B and tubulin expression (n/group: NR-CON = 9; R-CON = 10; NR-ETOH = 9; R-ETOH = 9). All data are expressed as the mean ± SEM. (*) Significantly different from NR-CON (p = .003), from NR-ETOH (p = .042) and from R-ETOH (p = .036). O.D: optical density. FC: fear conditioning. R: reactivated groups. NR: non-reactivated groups. ETOH: ethanol withdrawn rats. CON: control rats. 
Discussion
As expected, we found that PROP administration following reactivation of a 7-day memory did not reduce the fear response in a subsequent memory test in ETOH rats. However, pre-reactivation DCS injection promoted the vulnerability to the PROP disruptive effect on reconsolidation in these animals. Moreover, and in accordance with previous results (Bustos et al., 2010) , we observed that a 7-day fear memory in CON rats is vulnerable to reconsolidation interference. In conclusion, a limited dynamic after reactivation is observed in an older fear memory in ETOH rats. This evidence highlights a possible limitation for clinical interventions for the interference with the reconsolidation. As an alternative approach, we suggest that DCS/PROP administration in conjunction with memory reactivation could be an effective treatment to attenuate older fear memories involved in psychiatric disorders.
A resistance to PROP's interference of a fear memory and its reversion by DCS in ETOH rats has been only reported 1 day after training (Ortiz et al., 2015) , here we extended this phenomenon at least up to 1 week post-learning. Furthermore, since the attenuation of a fear memory 24 h after learning has a limited application in humans, our present findings provide evidence with major impact in the clinical context.
In agreement with other studies (Espejo et al., 2016; Jarome et al., 2016; Jarome et al., 2011) , fear memory reactivation increased the GluN2B subunit, polyubiquitinated proteins and proteasome activity in the BLA of CON rats. However, no differences were detected between R-ETOH animals and non-reactivated groups. The fact that ETOH animals displayed similar patterns to those observed in the NR-CON group discards a possible effect of ethanol withdrawal per se on the studied proteins. Thus, fear memory reactivation did not trigger the intracellular mechanisms in the BLA involved in the destabilization phase in ETOH animals. There is little information available related to the mechanisms involved in the resistance to reconsolidation disruption of a fear memory. Wang et al. indicated that a resistant memory induced by a strong training is associated with decreased GluN2B levels in the BLA 2 days after fear learning (Wang et al., 2009) . Therefore, it might be expected that NR-ETOH animals have less GluN2B expression with respect to NR-CON rats. However no such difference was found in the present study. This apparent discrepancy may have been due to the protocol used in generating a fear memory resistant to labilization (ethanol withdrawal vs intensive training), as well as the time at which the protein expression was evaluated (7 days vs 2 days, post-conditioning). In agreement with our results, reactivation of a fear memory resistant to labilization induced by stress did not increase GluN2B subunit expression in the BLA (Espejo et al., 2016) . In addition, the resistance to reactivationdependent memory destabilization is associated with an increase in the synaptic GluN2A/GluN2B ratio in the BLA (Holehonnur et al., 2016) . In summary, fear memory resistance to reconsolidation disruption is associated with an alteration in NMDA-R (GluN2B) expression in the BLA.
There is evidence that chronic ethanol consumption and withdrawal induce an increase in the expression of NMDA-R in the hippocampus, central amygdala and cortex (Krystal et al., 2003; McCool et al., 2010) , although studies in the BLA are scarce. Thus, alcohol dependence does not alter protein expression or mRNA levels of the GluN2B subunit in the BLA (Floyd et al., 2004; Obara et al., 2009 ). Related to this, we did not find any increase of the GluN2B subunit in the BLA in ETOH animals that were not subjected to memory reactivation.
Despite alcohol altering the protein degradation processes mediated by UPS in pathologies such as alcoholic liver disease (Bardag-Gorce et al., 2011; Osna, 2011) , evidence of the effects of ethanol dependence on UPS activity in the central nervous system is limited. An alteration in the UPS functioning in the cerebral cortex of mice subjected to ethanol consumption for 4 months was reported (Pla et al., 2014) . However, these findings are not comparable with the present results because here the UPS activity was evaluated in animals following ethanol withdrawal and then subjected to contextual fear conditioning. In addition, there are other differences between both studies, including: 1) the protocol of chronic consumption (liquid diet vs ethanol in the drinking water), 2) the duration of consumption (14 days vs 4 months), 3) the cerebral areas where the activity of the UPS was evaluated (BLA vs cerebral cortex), and 4) the animal species (rats vs mice).
Previous findings have indicated that ethanol withdrawal facilitates the formation of a robust, persistent contextual fear memory that is resistant to extinction (Bertotto et al., 2006) . Related to the molecular correlation of this exaggerated emotional response, it was found that alcohol dependence induces neuroadaptive changes in the properties or functioning of NMDA-R, in the activation of ERK protein kinases and in the expression of c-Fos in the brain structures involved in associative fear learning, including the BLA (Bertotto et al., 2010; Bertotto et al., 2011) . Moreover, other evidence from our laboratory indicated that ethanol withdrawal induces a reduction of GABAergic transmission in the BLA projection neurons (Isoardi et al., 2007 ) and a decreased surface expression of α1-containing GABAA receptors (Ortiz et al., 2015) . Such alterations may result in a hyperexcitability in the BLA, thereby favoring the formation of maladaptive fear memories in ETOH rats (Bertotto et al., 2006; Isoardi et al., 2007) . Considering these and the present findings, it could be suggested that withdrawal following chronic ethanol consumption modifies molecular pathways in the BLA, promoting an altered encoding of fear memory that prevents memory processing after reactivation.
The role of DCS as facilitator of destabilization of resistant memories had been only reported through behavioral studies (Espejo et al., 2016; Gazarini et al., 2014; Ortiz et al., 2015; Ortiz et al., 2016 ). Here we found that DCS restored the destabilization molecular events in the BLA after reactivation of a resistant fear memory in ETOH rats. With respect to this, the polyubiquitination levels and proteasome activity exhibited by ETOH-DCS animals were higher than those expressed in the ETOH-SAL group. Moreover, the ETOH-DCS group revealed a similar UPS activity to that observed in CON rats after reactivation. Nevertheless, given that we did not study the DCS effects on non-reactivated animals, we cannot discard the possibility that DCS per se enhances polyubiquitination or proteasome enzymatic activity in the BLA. However, it is important to note that DCS modulation on fear memory instability is dependent on reactivation (Bustos et al., 2010; Espejo et al., 2016; Gazarini et al., 2014; Ortiz et al., 2015; Ortiz et al., 2016) . Therefore, we can hypothesize that DCS ability to induce memory destabilization following reactivation, and in turn, to promote vulnerability to several disruptive agents may be due to its effect on UPS activity.
Summing up, the present findings indicate that: 1) the resistance to memory interference after reactivation in ETOH animals can be observed at least up to 7 days after training; 2) DCS/PROP treatment in conjunction with memory reactivation allows disrupting reconsolidation of older memory in ETOH rats; 3) the reactivation of an older fear memory does not trigger the molecular events in ETOH rats; and 4) DCS induces the destabilization of a resistant memory by enhancing the UPS activity.
Effective therapeutic strategies to reduce the influence of maladaptive memories in the maintenance of psychiatric disorders are required. Related to this, our results propose a potential effective pharmacological treatment for the attenuation of maladaptive older fear memories associated with drug addiction and fear-related disorders.
Furthermore, the molecular characterization after memory reactivation in ETOH rats reported here provides basis to determine in future studies the potential mechanisms involved in the resistance to destabilizationreconsolidation process.
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